[1
]
From the University of Washington (J.M.M.) and the Vaccine and Infectious Disease
Division, Fred Hutchinson Cancer Research Center (B.A.R., J.Y.D., B. Mâsse) - both
in Seattle; the HIV Prevention Research Unit, Medical Research Council (G.R., S.G.),
and the Centre for AIDS Programme of Research in South Africa (CAPRISA), Durban (G.N.),
Witwatersrand Reproductive Health and HIV Research Institute (T.P.) and Perinatal
HIV Research Unit (B. Mkhize), Johannesburg, and the AURUM Institute, Klerksdorp (M.T.)
- all in South Africa; FHI 360, Durham, NC (K.G.); University of Zimbabwe-University
of California San Francisco Research Programme, Harare, Zimbabwe (N.M., Z.M.C.); Makerere
University-Johns Hopkins University Research Collaboration, Kampala, Uganda (C.N.);
Women's Global Health Imperative, Research Triangle Institute (RTI) International,
San Francisco (A.S.); Magee-Womens Research Institute, University of Pittsburgh Medical
Center, Pittsburgh (L.N., U.M.P., S.L.H., I.M.M.); Johns Hopkins University School
of Medicine, Baltimore (C.W.H., M.A.M.); Division of AIDS, National Institute of Allergy
and Infectious Diseases (J.P.), National Institutes of Mental Health (C.G.), and the
Eunice Shriver Kennedy National Institute of Child Health and Human Development (H.W.),
National Institutes of Health - all in Bethesda, MD; Gilead Sciences, Foster City,
CA (J.R.); CONRAD, Arlington, VA (J.L.S.); and Centre Hospitalier Universitaire Sainte-Justine,
University of Montreal, Montreal (B. Mâsse).